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ABSTRACT  22 
South Asians living in the UK have a 1.5-fold greater risk of ischemic stroke than the 23 
general population. Impaired cerebrovascular carbon dioxide (CO2) reactivity is an 24 
independent predictor of ischemic stroke and cardiovascular mortality. We sought to test the 25 
hypothesis that cerebrovascular CO2 reactivity is reduced in South Asians. Middle cerebral 26 
artery blood velocity (MCA Vm) was measured at rest and during stepwise changes in partial 27 
pressure of end-tidal CO2 (PETCO2) in South Asian (n=16) and Caucasian European (n=18) 28 
men that were, young (~20 years), healthy and living in the UK. Incremental hypercapnia 29 
was delivered via the open circuit steady-state method, with stages of 4% and 7% CO2 (≈21% 30 
Oxygen, Nitrogen balanced). Cerebrovascular CO2 reactivity was calculated as the change in 31 
MCA Vm per mmHg change in PETCO2. MCA Vm was not different in South Asian (59 (9) 32 
cm/s; mean (standard deviation)) and Caucasian Europeans (61 (12) cm/s; P>0.05). Similarly, 33 
cerebrovascular CO2 reactivity was not different between the groups (South Asian, 2.53 34 
(0.76) cm/s/mmHg vs. Caucasian European, 2.61 (0.81) cm/s/mmHg; P>0.05). Brachial 35 
artery flow-mediated dilatation was lower in South Asian (5.48 (2.94) %) compared to 36 
Caucasian European (7.41 (2.28) %; P<0.05); however when corrected for shear rate, no 37 
between group differences in flow-mediated dilatation were observed (P>0.05). Flow-38 
mediated dilation was not correlated with cerebrovascular CO2 reactivity measures. In 39 
summary, cerebrovascular CO2 reactivity and flow-mediated dilation when corrected for 40 
shear rate are preserved in young healthy South Asian men living in the UK.  41 
 42 
Keywords: brain, cerebral circulation, flow-mediated dilatation.  43 
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NEW AND NOTEWORTHY 44 
Previous reports have identified an increased risk of ischemic stroke and peripheral 45 
endothelial dysfunction in South Asians compared to Caucasian Europeans. The main finding 46 
of this study is that cerebrovascular carbon dioxide reactivity (an independent predictor of 47 
ischemic stroke) is not different in healthy young South Asian and Caucasian European adult 48 
men.  49 
 50 
ABBREVIATIONS  51 
BP, blood pressure; CO2, carbon dioxide; CVCi, cerebrovascular conductance index; 52 
ECG, electrocardiograph; FMD, flow-mediated dilation; FMDc, covariate corrected flow-53 
mediated dilation; HR, heart rate; MAP, mean arterial pressure; MCAV, middle cerebral 54 
artery mean blood velocity; N2, nitrogen; O2, oxygen; PETCO2, partial pressure of end-tidal 55 




South Asian migrants from the Indian sub-continent in the United Kingdom have an 58 
ischemic stroke mortality that is ~1.5 times greater than the general population (44), while 59 
ischemic stroke onset typically occurs at a younger age in South Asians than ethnically White 60 
Caucasian Europeans (20). Although broadly attributable to cultural and socioeconomic 61 
factors (12), there is a paucity of information about the underlying physiological mechanisms 62 
for such ethnic differences in cerebrovascular health (37). The brain has a high metabolic 63 
demand and possesses multiple interactive regulatory mechanisms. The latter ensure that 64 
cerebral blood flow remains relatively stable independent of changes in perfusion pressure 65 
(cerebral autoregulation), that local perfusion is closely matched to neuronal activation and 66 
metabolism (neurovascular coupling), and that cerebrovascular responses to changes in 67 
carbon dioxide (cerebrovascular CO2 reactivity) are adequate to assist the maintenance of 68 
central [H+]. Bathula et al. (4) observed that cerebral autoregulation is poorer and 69 
cerebrovascular resistance is higher in South Asians (of Punjabi Sikh origin) compared to 70 
people with “European origins”. However, it remains to be determined whether 71 
cerebrovascular CO2 reactivity is blunted (i.e., diminished cerebral vasodilatory reserve) in 72 
South Asians.  73 
It has long been established that the cerebral vasculature is highly sensitive to changes 74 
in the partial pressure of arterial CO2 (19), and since this time an impaired cerebrovascular 75 
CO2 reactivity has been established as an independent predictor of ischemic stroke (23) and 76 
identified in several cardiovascular, cerebrovascular and neurological disorders (13, 18, 23, 77 
41). Cerebrovascular dysfunction may lead to neuronal dysfunction and neurodegeneration 78 
since neurons depend on arterial vasodilatation for adequate perfusion to ensure oxygen/CO2 79 
homeostasis, nutrient delivery and elimination of potentially toxic metabolites (46). The 80 
mechanism whereby CO2 modifies cerebral blood vessel tone is complex. Among the various 81 
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contributory factors, endothelium-derived nitric oxide is considered to be an important local 82 
regulator of cerebral blood flow that plays a role in hypercapnia-induced vasodilatation (14, 83 
40, 43). Indeed, acute infusion of L-arginine (the substrate for endothelial nitric oxide 84 
synthase) restores impairments in cerebrovascular CO2 reactivity manifest in patients with 85 
cardiovascular risk factors (45), while hypercapnia-induced increases in cerebral blood flow 86 
are attenuated by inhibition of nitric oxide synthase activity with N-nitro-L-arginine methyl 87 
ester (L-NAME) in rats (5). Moreover, individuals or groups in whom impaired peripheral 88 
vascular nitric oxide signaling has been identified are reported to demonstrate a reduced 89 
cerebrovascular CO2 reactivity (21). Therefore, the observation that brachial artery flow-90 
mediated dilation, indicative of attenuated endothelium-derived nitric oxide mediated 91 
vasodilation, is reduced in South Asians compared to Caucasian Europeans (6, 30) may also 92 
point to a reduced cerebrovascular CO2 reactivity.  93 
The aim of this study was to investigate whether cerebrovascular CO2 reactivity is 94 
impaired in young healthy South Asians compared to Caucasian Europeans. Based on prior 95 
reports identifying the greater incidence of cerebrovascular events in South Asians and 96 
peripheral endothelial dysfunction, we hypothesized that cerebrovascular CO2 reactivity 97 
would be lower in healthy young South Asian adults when compared to age-matched 98 
Caucasian Europeans. Brachial artery flow-mediated dilation, a well-established marker of 99 
peripheral vascular (endothelial) function, was also determined in accordance with 100 
established guidelines (32, 42). Lastly, we assessed whether an association between brachial 101 
artery flow-mediated dilation and cerebrovascular CO2 reactivity existed in the population 102 




Ethical Approval. 105 
The experiments were undertaken in accordance with the Declaration of Helsinki, 106 
except for registration in a database, and were approved by the University of Birmingham, 107 
Science, Technology, Engineering and Mathematics Ethical Review (approval number 108 
ERN_17-1161). Written informed consent was obtained from all participants after each had 109 
received a detailed verbal and written explanation of the study procedures.  110 
 111 
Participant characteristics. 112 
Sixteen South Asians with ethnic roots in Indian-Subcontinent (Bangladesh, India, 113 
Maldives, Nepal, Pakistan and Sri Lanka) and eighteen Caucasian Europeans living in the 114 
UK volunteered for this study. Accordingly, each participant confirmed the ethnic origins of 115 
all four of their grandparents. South Asian participants were first or second-generation 116 
migrants. No participant had a known history of pulmonary, cardiovascular, metabolic or 117 
neurological diseases and were not taking prescription or over-the-counter medication. One 118 
participant in each group was found to have raised blood pressure and recommended to have 119 
an appointment with their general practitioner. Upon follow-up both were confirmed as being 120 
normotensive. All participants were accustomed to recreational exercise, but none was a 121 
competitive athlete. 122 
 123 
Experimental measures. 124 
Height and weight, along with waist (level of the umbilicus) and hip (level of the 125 
femoral trochanter) circumference were measured. Heart rate (HR) was monitored using a 126 
lead II electrocardiogram (ECG) (Morgan 509 Cardiac Monitor, Kent, UK). Arterial blood 127 
pressure (BP) was measured continuously using finger photoplethysmography (Portpress, 128 
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Finapres Medical Systems BV, Amsterdam, The Netherlands) and corrected with automatic 129 
brachial sphygmomanometer readings (Omorn 750IT, Milton Keynes, UK). Middle cerebral 130 
artery mean blood velocity (MCA Vm) was continuously monitored using transcranial Dopper 131 
ultrasonography (Doppler Box X, DWL, Sipplingen, Germany). A 2 MHz probe, mounted on 132 
an adjustable headband, was fixed at the temporal window to insonate the right MCA at a 133 
depth of 40-65 mm. Participants wore a mouthpiece and nose-clip, and the partial pressure of 134 
end-tidal CO2 (PETCO2) was provided by a capnograph connected to the mouthpiece by an 135 
anesthetic sample line (Gas Analyzer, ADInstruments, Dunedin, New Zealand). Breath-by-136 
breath fluctuations in PETCO2 were used to calculate respiratory rate. Analogue signals were 137 
digitized at 1 kHz (Powerlab, ADInstruments) and recorded using multi-channel data 138 
acquisition software (LabChart 7, ADInstruments). Simultaneous recordings of the left 139 
brachial artery diameter and flow velocity were obtained with the arm at heart level using 140 
Doppler ultrasound (Terason uSmart 3300, Teratech Corporation, Burlington, MA, USA). 141 
The artery was insonated 10–15 cm proximal to the medial epicondyle at 60°. Duplex 142 
imaging was used to obtain a B-mode image of vessel diameter and pulse-wave mode of peak 143 
blood velocity using a 4-15 Hz multi-frequency linear-array transducer (Terason uSmart 144 
15L4) held in place with an adjustable probe holder. Ultrasound measurements were made in 145 
accordance with technical recommendations (32, 42). Recordings were screen captured, 146 
stored as video files and offline analysis carried out using automated edge detection and wall 147 
tracking software (Cardiovascular Suite Version 3.4.1, FMD Studio, Pisa, Italy) (11). 148 
 149 
Experimental Protocol   150 
This cross-sectional study included a screening/familiarization visit prior to the 151 
experimental session. Participants were instructed to abstain from food for 2 h, caffeinated 152 
beverages for 12 h, strenuous exercise for 24 h and multi-vitamin use for 7 days before 153 
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experimental sessions. The study was conducted in a temperature controlled cardiovascular 154 
laboratory (21–24 ℃). Participants were asked to lie supine comfortably for ~10 min on a 155 
medical examination couch. A narrow inflatable cuff (5 cm width, Hokanson, Bellevue, WA, 156 
USA) was placed 5-7 cm distal to the medial epicondyle. The flow-mediated dilatation 157 
protocol was then conducted with the brachial artery insonnated for the simultaneous 158 
measurement of diameter and flow velocity. The flow-mediated dilatation protocol comprised 159 
of a 2 min baseline, a 5 min cuff inflation to a supra-systolic pressure of > 240 mmHg and a 3 160 
min recovery period with the cuff deflated. 161 
To assess cerebrovascular CO2 reactivity a 10-min baseline was acquired while 162 
participants breathed room air. During this period, a minimum of 3 brachial artery blood 163 
pressure readings were obtained using the automated sphygmomanometer. Participants then 164 
breathed gas mixtures from a Douglas bag containing air enriched with CO2 (hypercapnia), 165 
via a two-way non-rebreathing valve. Specifically, participants received 4 % CO2 (≈21 % O2, 166 
N2 balanced) for 4-min, followed by 7 % CO2 (≈21 % O2, N2 balanced) for 4 min, then were 167 
switched back to room air (18, 33). Hemodynamic and respiratory parameters were recorded 168 
throughout and once these had returned to baseline, participants were asked to increase their 169 
respiratory depth and rate in order to achieve an equal but opposite change in their PETCO2 as 170 
during the hypercapnic challenge, with each step lasting 2 min (hypocapnia).  171 
 172 
Data analysis 173 
Body mass index (BMI) was expressed as the ratio of the participants’ weight and the 174 
height squared. Digitally recorded data were extracted in an anonymized manner. Mean 175 
arterial pressure (MAP) was the mean blood pressure over each cardiac cycle. Brachial artery 176 
blood flow was calculated as:  177 
Brachial artery blood flow = [Peak Envelope Velocity 2 ∙ (𝜋 (0.5 ∙ Diameter) )] ∙ 60 
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Brachial artery flow-mediated dilatation was taken as the maximal change in brachial 178 
artery diameter following cuff deflation. The time to peak diameter was obtained between the 179 
cuff deflation and the maximal artery dilation, and time to peak blood flow (reactive 180 
hyperemia) was obtained between cuff deflation and maximal flow velocity. Shear rate was 181 
calculated as brachial artery blood velocity multiplied by 4 and divided by brachial artery 182 
diameter. Shear rate area under the curve (SRAUC) was calculated as an integral between the 183 
cuff deflation and the maximal artery dilation. Flow-mediated dilatation was expressed as 184 
absolute and relative change in diameter. A ratio between flow-mediated dilatation and 185 
SRAUC (FMD-to-SRAUC ratio) was also calculated and multiplied by 1000 (32, 42). Further, 186 
based on recent guidelines (2), baseline and maximal brachial artery diameters were log-187 
transformed and the difference between them calculated. Logged difference in diameter was 188 
entered in an analysis of covariance (ANCOVA) where ethnicity constituted a fixed factor 189 
and log-transformed baseline diameter a covariate. The covariate adjusted means were then 190 
back-transformed and expressed as percentage changes for covariate corrected flow-mediated 191 
dilatation (FMDC).  192 
Cerebrovascular conductance index (CVCi) was calculated as MCA Vm / MAP. 193 
Baseline values are taken as mean of the whole 10-min baseline period. For cerebrovascular 194 
CO2 reactivity, values were acquired over the last minute of each hypercapnic and 195 
hypocapnic step. Cerebrovascular CO2 reactivity was assessed using linear and exponential 196 
models (39). For exponential model, values of the exponent and R2 and for linear model, the 197 
values of slope and R2 of % change in (∆) MCA Vm and % ∆ CVCi versus PETCO2 (mmHg) 198 
were calculated. Cerebrovascular CO2 reactivity was separately expressed as the linear slope 199 
of ∆ MCA Vm (cm/s) and ∆ CVCi (cm/s/mmHg) versus the change in PETCO2 in mmHg, 200 
between the two hypercapnic steps and two hypocapnic steps (18, 33). Additional analyses of 201 
cerebrovascular CO2 reactivity were undertaken by calculating the slope of % ∆ MCA Vm 202 
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and % ∆ CVCi versus ∆ PETCO2 (in mmHg) with the hypercapnic and hypocapnic steps (9, 203 
31). 204 
 205 
Statistical Analysis  206 
Data distribution was assessed by the Shapiro-Wilk test. Normally distributed data 207 
were analyzed using two-tailed Students t-test, while non-normally distributed data were 208 
analyzed using Mann-Whitney Rank Sum test. The correlation between cerebrovascular CO2 209 
reactivity and flow-mediated dilatation was assessed using Pearson’s product moment 210 
correlation. Effect size (Cohen’s d) was calculated as the difference between means of two 211 
groups divided by the averaged standard deviation (SD). Statistical analysis was performed 212 
using Sigmaplot 13.0 (Systat Software Inc, London, UK). Significance was set at p < 0.05. 213 
Normally distributed data are presented as mean (SD), unless stated, while non-normally 214 
distributed data are presented as median [interquartile range].    215 
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RESULTS  216 
Participant characteristics and baseline haemodynamics 217 
Participant characteristics are presented in Table 1. Groups were closely matched for 218 
age, weight, BMI and waist-to-hip ratio. At baseline, no between-group differences in heart 219 
rate, systolic BP, diastolic BP and respiratory rate were observed. Similarly, MCA Vm, CVCi 220 
and MAP were not different between the South Asian and Caucasian European groups 221 
(P>0.05), however PETCO2 was lower in South Asians (P<0.05; Figure 1).  222 
 223 
Cerebrovascular CO2 reactivity 224 
Figure 2 shows the MCA Vm, CVCi and MAP response to both the hypercapnic and 225 
hypocapnic steps of the cerebrovascular CO2 reactivity test in the South Asian and Caucasian 226 
European groups. As anticipated, hypercapnia produced pronounced increases in MCA Vm 227 
and CVCi, while conversely both were reduced with hypocapnia. Of note, no between-group 228 
differences were observed in any index of cerebrovascular CO2 reactivity (Figure 3, Table 2).  229 
 230 
Brachial artery flow-mediated dilatation 231 
Flow-mediated dilatation was lower in the South Asian than Caucasian European 232 
group (P<0.05, Figure 4). This between group difference persisted with correction for 233 
baseline diameter (FMDC P<0.05, Table 3). Peak reactive hyperemia was not different 234 
between groups (P>0.05, Table 3). However, SRAUC was lower in South Asians than 235 
Caucasian Europeans (P<0.05, Table 3) and when brachial artery flow-mediated dilatation 236 
was corrected for SRAUC (i.e., FMD-to-SRAUC ratio) the between group difference was no 237 
longer evident (P>0.05, Figure 4). No significant association between FMDc and hypercapnic 238 
cerebrovascular CO2 reactivity (4% to 7%; Figure 3) was observed either for the whole group 239 
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(r = 0.08, P = 0.669), or individually for South Asians and Caucasian Europeans (r = -0.05, P 240 
= 0.854 and r = 0.18, P = 0.475, respectively).  241 
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DISCUSSION   242 
The major novel finding of the present study is that cerebrovascular CO2 reactivity is 243 
not different in young healthy South Asians and Caucasian Europeans. In addition, brachial 244 
artery flow-mediated dilatation was lower in South Asians when expressed as a percentage 245 
change from baseline. However, during flow-mediated dilation testing South Asians had a 246 
lower shear rate response (SRAUC), which when accounted for (FMD-to-SRAUC ratio), flow-247 
mediated dilatation was not different between groups. These findings suggest that: 1) 248 
contrary to our hypothesis, cerebrovascular CO2 reactivity is not lower in healthy young 249 
South Asian adults than age-matched Caucasian Europeans, and 2) apparent reductions in 250 
brachial artery flow-mediated dilatation in South Asians (6, 30) may be attributable to a 251 
reduced ischemic stimulus rather than endothelial dysfunction per se.  252 
Prior reports have identified a greater incidence of cerebrovascular events in South 253 
Asians (20, 44). Given the prognostic significance of impaired cerebrovascular CO2 reactivity 254 
as an independent predictor of ischemic stroke (23) and its association with multiple 255 
cardiovascular, cerebrovascular and neurological disorders (13, 18, 23, 41), we anticipated 256 
that cerebrovascular CO2 reactivity would be lower in South Asian adults than age-matched 257 
Caucasian Europeans. Moreover, Hurr et al. (15) identified that African Americans (23±4 258 
years), a group at higher risk of cardiovascular and cerebrovascular disease, exhibited an 259 
attenuated cerebrovascular vasodilatation in response to hypercapnia compared to age-260 
matched Caucasian Americans. Contrary to expectation, we did not observe a difference in 261 
cerebrovascular CO2 reactivity between young healthy South Asian and Caucasian European 262 
men; neither did we observe between-group differences in MCA Vm nor CVCi. In a 263 
population-based sample Bathula et al. (4) noted a higher MCA Vm (38.0±0.7 vs. 41.4±0.7 264 
cm/s) and cerebrovascular resistance (resistivity index), but poorer cerebral autoregulation 265 
(low frequency gain, 0.45±0.01 vs. 0.50±0.01 cm/s/mmHg) in South Asians of Punjabi Sikh 266 
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origin (n=127) compared to people with “European origins” (n=128). Interestingly, the 267 
elevated cerebrovascular resistance in South Asians was attributable to hyperglycaemia (e.g., 268 
blood glucose, glycated haemoglobin). The cohort studied by Bathula et al. (4) had a wide 269 
age range (35-75 years) and comorbidities, including hypertension, diabetes, coronary heart 270 
disease and metabolic syndrome, which perhaps is reflected in their comparatively low MCA 271 
Vm values (7, 17, 18, 29). However, this is in contrast to the young and healthy participants 272 
recruited to the present study and may explain why we did not observe any differences in 273 
MCA Vm, CVCi and cerebrovascular CO2 reactivity between the South Asian and Caucasian 274 
European groups studied.  275 
 Coronary heart disease risk is elevated in migrant South Asians to the UK (3, 25). Of 276 
note, according to the 1991 England and Wales Census data, the relative risk of death from 277 
coronary heart disease was 3 in Indian Asian men aged 20-29 years, compared to age-278 
matched Caucasian Europeans (3). The excess coronary heart disease risk in South Asians is 279 
not explained by conventional risk factors (e.g., smoking, hypercholesterolemia, 280 
hypertension) (24), although an increased prevalence of insulin resistance and diabetes has 281 
been implicated (26). Endothelial dysfunction in South Asians (i.e., attenuated brachial artery 282 
flow-mediated dilatation and NG-Monomethyl-L-arginine induced vasoconstriction) is also 283 
speculated to contribute to the elevated coronary heart disease risk, and has been identified in 284 
both young (30) and older (6) South Asian groups. In the present study when we expressed 285 
flow-meditated dilatation simply as the percentage change from baseline in brachial artery 286 
diameter, it was reduced in South Asians compared to Caucasian Europeans. This 287 
experimental approach and the associated findings are in agreement with previous reports (6, 288 
30). It is noteworthy that despite no differences in baseline brachial artery diameter, velocity 289 
and blood flow, the SRAUC was attenuated in the South Asian group. Accordingly, when 290 
flow-mediated dilatation responses were adjusted to account for this (i.e., via the FMD-to-291 
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SRAUC ratio), the between group difference was no longer observed. This is important 292 
because the magnitude of the evoked shear stress is mechanistically coupled with the 293 
dilatation observed, but no previous studies reporting a blunted flow-mediated dilatation in 294 
South Asians versus European Caucasians have accounted for this (6, 20, 30, 44). In 295 
accordance with recent guidelines (32, 42), it is deemed important to account for shear stress 296 
when making between group comparisons. The reason for the lower SRAUC in South Asian 297 
group is unclear, but may relate to a lower maximal vascular conductance and/or attenuated 298 
metabolic vasodilation induced by ischemia. Indeed, as the hyperemia dynamics are coupled 299 
with metabolism, it is a possible that the results of this study reflect a lower and/or altered 300 
metabolic response to ischemia in South Asians; a possibility that requires further 301 
investigation. 302 
Brachial artery flow-mediated dilatation and hypercapnia-induced cerebral 303 
vasodilatation share common mechanisms, with endothelial derived nitric oxide reported to 304 
mediate both, at least partially (14, 16, 40, 43). In the population-based Rotterdam Study, 305 
Portegies et al. (36) observed that lower cerebrovascular CO2 reactivity was associated with 306 
an increased risk of all-cause mortality (1.10, 95% confidence interval [CI] 1.01-1.19), 307 
cardiovascular mortality (1.09 [95% CI 0.94-1.26]) and non-cardiovascular mortality (1.10 308 
[95% CI 0.99-1.21]), which points towards cerebrovascular CO2 reactivity being more 309 
broadly associated with systemic vascular dysfunction. Moreover, brachial artery endothelial 310 
dysfunction (i.e., attenuated forearm reactive hyperemia) and impaired cerebrovascular CO2 311 
reactivity coexist in patients with long standing diabetes and/or hypertension (21). Similarly, 312 
both an impaired cerebrovascular responses to hypercapnia (15) and an attenuated brachial 313 
artery flow-mediated dilatation (34) have been identified in African Americans, relative to 314 
Caucasian Americans, albeit not in the same cohort. In contrast, we observed no association 315 
between cerebrovascular CO2 reactivity and brachial artery flow-mediated dilatation in our 316 
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study population, which possibly reflects the young and healthy cohort with a relatively 317 
narrow (i.e., normal) range of vascular responsiveness.  318 
The results of this study should be viewed in the context of the following 319 
experimental limitations. Despite the widely acknowledged value of transcranial Doppler in 320 
the evaluation of cerebral vascular function, it is an inherent limitation of the method that 321 
MCA Vm is only proportional to cerebral blood flow if the cross-sectional area of the MCA 322 
remains unchanged. Although, good correlations have been observed between MCA Vm and 323 
cerebral blood flow when PETCO2 is altered (8, 35), there is evidence to suggest MCA 324 
diameter increases with robust hypercapnia (i.e., Δ PETCO2 of greater than ~7-9 mmHg) (1, 325 
22, 28). PETCO2 has been employed as a non-invasive surrogate for the partial pressure of 326 
arterial CO2 (PaCO2) in the present study because a strong positive linear correlation between 327 
PETCO2 and PaCO2 has been identified (27); however, it is acknowledged that PETCO2 may 328 
underestimate PaCO2 at rest (38). We also acknowledge the ongoing debate relating to the 329 
relative strengths and weaknesses of approaches developed to determine cerebrovascular CO2 330 
reactivity (10). The method used here has shown a good between-day test-retest reliability 331 
(intraclass correlation of 0.938 [95% CI 0.759-0.985] P<0.001; co-efficient of variation for 332 
the method error of 6.06%) (18). The extent to which our findings may be more broadly 333 
generalized is limited by the inclusion of only healthy young men. We also failed to collect 334 
diet and socioeconomic data for the participants and did not objectively assess their activity 335 
patterns in a detailed manner. Future studies should consider the important potential 336 
interaction between sex, aging, diet, socioeconomic levels, activity patterns and ethnicity in 337 
the regulation of peripheral vasculature and cerebrovascular function. 338 
In summary, we report for the first time that cerebrovascular CO2 reactivity is not 339 
different in young healthy South Asians and Caucasian Europeans. Furthermore, when the 340 
brachial artery flow-mediated dilatation response was expressed relative to the shear stress 341 
17 
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South Asian  P value 
n 18 16  
Age (years) 21 [20-22] 21 [20-25] 0.505 
Height (cm) 1.80 (0.07) 1.76 (0.06) 0.074 
Weight (kg) 75.0 (8.5) 76.1 (11.4) 0.733 
BMI (kg/m2) 23.2 (2.4) 24.7 (3.2) 0.139 
Waist circumference (cm) 78 [77-81] 80 [75-89] 0.387 
Hip circumference (cm) 97 [95-98] 99 [93-100] 0.341 
Waist / Height ratio (au) 0.44 (0.03) 0.47 (0.06) 0.050 
Waist / Hip ratio (au) 0.80 [0.79-0.84] 0.82 [0.78-0.86] 0.557 
Heart rate (b·min-1) 63 [58-66] 67 [58-73] 0.248 
Systolic BP (mmHg) 124 (9) 119 (9) 0.070 
Diastolic BP (mmHg) 67 [63-71] 67 [64-72] 0.972 
Respiratory rate (b·min-1) 14 [13-15] 15 [13-16] 0.343 
 481 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] 482 
when non-normally distributed. BMI, body mass index; au, arbitrary units.  483 
  484 
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Table 2. Cerebrovascular CO2 reactivity parameters. 485 
 
 




MCA Vm % (%·mmHg-1) Linear Slope 3.06 [2.77-3.18] 3.26 [2.83-3.45] 0.064 0.221 
 R2 0.96 (0.02) 0.95 (0.04) 0.316 0.397 
 Exponent 0.029 [0.027-0.031] 0.030 [0.028-0.032] 0.126 0.691 
 R2 0.99 [0.97-0.99] 0.98 [0.96-0.99] 0.500 0.221 
CVCi % (%·mmHg-1) Linear Slope 2.62 [2.26-2.83] 2.87 [2.66-3.29] 0.234 0.076 
 R2 0.96 [0.93-0.98] 0.94 [0.92-0.98] 0.250 0.458 
 Exponent 0.027 [0.024-0.028] 0.028 [0.025-0.029] 0.105 0.629 
 R2 0.96 [0.94-0.98] 0.96 [0.93-0.97] 0.123 0.605 
Hypercapnic MCA Vm Slope (cm·s-1·mmHg-1) BL to 4% 1.49 [1.34-2.32] 1.84 [1.23-2.24] 0.083 0.931 
 4% – 7% 2.61 (0.81) 2.53 (0.76) 0.102 0.754 
Hypocapnic MCA Vm Slope (cm·s-1·mmHg-1) BL to -4% 1.83 (1.10) 1.97 (1.03) 0.131 0.849 
 -4% – -7% 1.00 (0.57) 0.92 (0.53) 0.145 0.656 
Hypercapnic CVCi Slope (cm·s-1·mmHg-2) BL to 4% 0.017 (0.014) 0.022 (0.013) 0.370 0.282 
 4% to 7% 0.023 (0.009) 0.022 (0.011) 0.099 0.769 
Hypocapnic CVCi Slope (cm·s-1·mmHg-2) BL to -4% 0.025 (0.017) 0.024 (0.014) 0.064 0.934 
 -4% to -7% 0.008 [0.005-0.014] 0.010 [0.002-0.014] 0.124 0.617 
Hypercapnic %∆ MCA Vm /∆ PETCO2 (%·mmHg-1) BL to 4% 3.02 [2.07-3.74] 3.06 [2.31-4.12] 0.079 0.666 
 4% to 7% 3.57 [3.24-4.00] 3.68 [3.22-4.03] 0.072 0.986 
24 
 
Hypocapnic %∆ MCA Vm /∆ PETCO2 (%·mmHg-1) BL to -4% 3.37 (1.69) 3.35 (1.64) 0.012 0.979 
 -4% to -7% 1.99 (0.67) 1.87 (0.87) 0.154 0.662 
Hypercapnic %∆ CVCi /∆ PETCO2 (%·mmHg-1) BL to 4% 2.36 (1.92) 3.28 (2.08) 0.460 0.186 
 4% to 7% 2.92 (1.27) 2.65 (1.46) 0.197 0.572 
Hypocapnic %∆ CVCi /∆ PETCO2 (%·mmHg-1) BL to -4% 3.51 (2.14) 3.53 (2.06) 0.009 0.969 
 -4% to -7% 1.82 (1.17) 1.55 (1.33) 0.215 0.529 
 486 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] when non-normally distributed. BL, baseline; R2, 487 
coefficient of determination; 4%, first hypercapnic step containing 4% CO2; 7%, second hypercapnic step containing 7% CO2; -4%, first 488 
hypocapnic step intended to produce an equal and opposite change in PETCO2 as observed with 4% CO2; -7%, second hypocapnic step intended 489 




Table 3. Flow-mediated dilatation parameters in Caucasian Europeans and South Asians. 492 
 




Baseline diameter (mm) 4.13 [3.83-4.37] 4.30 [4.03-4.51] 0.194 0.285 
Baseline velocity (cm.s-1) 11.82 [8.65-20.29] 13.11 [11.28-29.65] 0.579 0.208 
Baseline blood flow (ml.min-1) 49.32 [37.01-75.30] 59.31 [42.07-143.41] 0.632 0.196 
Peak diameter (mm) 4.47 [4.14-4.68] 4.55 [4.29-4.79] 0.011 0.666 
Peak blood flow (ml.min-1) 363.37 (108.93) 339.88 (128.06) 0.197 0.567 
Time to peak flow (s) 12.50 [11.00-14.75] 11.50 [9.75-13.50] 0.047 0.404 
Absolute FMD (mm) 0.31 (0.09) 0.23 (0.13) 0.715 0.062 
Time to peak diameter (s) 68.28 (27.24) 66.56 (24.72) 0.066 0.849 
FMDC (%) 7.39 (2.28) 5.51 (2.94) 0.715 0.044 
SRAUC (s-1) 19028.11 (8991.70) 12519.81 (5091.05) 0.891 0.016 
 493 
Values are displayed as mean (SD) when normally distributed or median [interquartile range] 494 
when non-normally distributed. FMD, flow-mediated dilatation; FMDC, corrected flow-495 
mediated dilatation; SRAUC, shear rate area under the curve.  496 




FIGURE LEGENDS 499 
Figure 1. Baseline MCA Vm, CVCi, MAP and PETCO2 in Caucasian Europeans and 500 
South Asians. MCA Vm, middle cerebral artery mean flow velocity; CVCi, cerebrovascular 501 
conductance index; MAP, mean arterial pressure; PETCO2 , partial pressure of end-tidal 502 
carbon dioxide. Data expressed as individual values and means with SD. * represents P 503 
<0.05. 504 
 505 
Figure 2. MCA Vm, CVCi and MAP responses to the cerebrovascular CO2 reactivity 506 
protocol in Caucasian Europeans and South Asians. Symbols show mean and standard 507 
error of the mean.  508 
 509 
Figure 3. Cerebrovascular CO2 reactivity in Caucasian Europeans and South Asians. 510 
Cerebrovascular CO2 reactivity is expressed as the slope of MCA Vm change in cm/s (∆) 511 
(panel A) and ∆ CVCi (panel B) versus ∆ PETCO2 in mmHg. Horizontal bars show mean and 512 
SD.  513 
 514 
Figure 4. Flow-mediated dilatation (FMD) in Caucasian Europeans and South Asians. 515 
FMD is expressed as a percentage change (panel A) and as a ratio between FMD (%) and 516 
SRAUC (panel B). Horizontal bars show mean and SD.  517 
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